3 recruiting, 1 active not recruiting, 1 completed. 2 Not applicable, 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Recruiting 1 |
| Phase 1 | 2 | Active not recruiting 1, Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Recurrent Paranasal Sinus Squamous Cell Carcinoma: new trials by email Literature Review of Recurrent Paranasal Sinus Squamous Cell Carcinoma trials Research Report on Recurrent Paranasal Sinus Squamous Cell Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma Biospecimen Collection, Camonsertib, Computed Tomography - Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Recurrent Head and Neck Squamous Cell Carcinoma | Phase 1 | Recruiting | National Cancer Institute (NCI) | 39 | 2027-02-13 | 2026-09-03 |
| Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation Audiometric Test, Interview - Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Cutaneous Squamous Cell Carcinoma of the Head and Neck | Not applicable | Recruiting | Emory University | 118 | 2025-08-25 | 2026-07-16 |
| Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial Biospecimen Collection, Computed Tomography, Lovastatin - Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Human Papillomavirus-Related Neck Squamous Cell Carcinoma of Unknown Primary | Phase 2 | Recruiting | Emory University | 28 | 2024-12-09 | 2026-02-11 |
| Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer Biospecimen Collection, Computed Tomography, Elimusertib - Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Phase 1 | Active not recruiting | National Cancer Institute (NCI) | 7 | 2022-07-06 | 2026-08-21 |
| Prepare to Care, A Supported Self-Management Intervention for Head and Neck Cancer CaregiversHead and Neck Cancer Communication Intervention, Watch video, Module completion of the Prepare to Care kit - Caregiver, Malignant Head and Neck Neoplasm | Not applicable | Completed | Wake Forest University Health Sciences | 35 | 2017-05-15 | 2023-01-09 |
Squamous Cell Carcinoma of Head and Neck (5) · Carcinoma (4) · Hypopharyngeal Neoplasms (4) · Laryngeal Neoplasms (4) · Mouth Neoplasms (4) · Oropharyngeal Neoplasms (4) · Nasopharyngeal Carcinoma (2) · Head and Neck Neoplasms (1) · Lymphoid Interstitial Pneumonia (1) · Salivary Gland Neoplasms (1)
Carcinoma, Squamous Cell (5) · Neoplasms (5) · Neoplasms by Histologic Type (5) · Neoplasms by Site (5) · Neoplasms, Glandular and Epithelial (5) · Head and Neck Neoplasms (4) · Laryngeal Diseases (4) · Mouth Diseases (4) · Otorhinolaryngologic Diseases (4) · Otorhinolaryngologic Neoplasms (4) · Pharyngeal Diseases (4) · Pharyngeal Neoplasms (4) · Respiratory Tract Diseases (4) · Respiratory Tract Neoplasms (4) · Stomatognathic Diseases (4)
Magnetic Resonance Spectroscopy (3) · Specimen Handling (3) · Radiosurgery (2) · pembrolizumab (2) · BAY 1895344 (1) · Educational Status (1) · Hearing (1) · Interviews as Topic (1) · Lovastatin (1) · Methods (1)
Emory University (2) · National Cancer Institute (NCI) (2) · Wake Forest University Health Sciences (1)
United States (5)
Yvonne M Mowery (2) · Chandylen Nightingale (1) · Nicole C Schmitt, D, FACS (1) · Nicole C Schmitt, MD, FACS (1)
P30CA138292 (2), UM1CA186690 (2), K24DC022077 (1), P30CA012197 (1), R03CA208560 (1)